Aurobindo unit gets USFDA nod to market generic asthma medication
Eugia Pharma Specialities has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Budesonide Inhalation Suspension, the Hyderabad-based drug firm said in a regulatory filing.
As per IQVIA data, the approved product has an estimated market size of USD 226.4 million for the 12 months ended September 2023. Pic: Reuters